Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
11/2009
11/03/2009US7612092 Nitrogen-containing aromatic derivatives
11/03/2009US7612090 Use in treatment of a disorder which is created by or is dependent upon decreased availability of serotonin, norepinephrine or dopamine
11/03/2009US7612075 Anticaogulants; cardiovascular disorders
11/03/2009US7612068 (S)-1-{2-[2-(4-Fluoro-phenylsulfanyl)-phenoxy]-ethyl}-pyrrolidine-2-carboxylic acid; glycine transport inhibitors; for schizophrenia and other psychoses
11/03/2009US7612064 Sulfopyrroles
11/03/2009CA2497074C Substituted spirocyclic ketoenols
11/03/2009CA2474510C Fused tricyclic heterocycles useful for treating hyper-proliferative disorders
11/03/2009CA2443724C Novel, arylsusfonamide compounds for the treatment of obesity, type ii diabetes and cns-disorders
11/03/2009CA2442423C Therapeutic drug for psychoneurotic disorders
10/2009
10/29/2009WO2009132202A2 Macrocyclic compounds and their use as kinase inhibitors
10/29/2009WO2009132097A1 Substituted gamma lactams as therapeutic agents
10/29/2009WO2009132088A1 Substituted gamma lactams as therapeutic agents
10/29/2009WO2009131196A1 Substituted pyrrolidine derivative and use thereof
10/29/2009WO2009131135A1 Iminopyridine derivative and use thereof
10/29/2009WO2009130193A1 Fungicide hydroximoyl-heterocycles derivatives
10/29/2009WO2009106980A3 Indazole derivatives
10/29/2009US20090270409 Compounds and compositions as modulators of gpr119 activity
10/29/2009US20090270367 Substituted hydroxyethylamine aspartyl protease inhibitors
10/29/2009US20090270365 such as N-(2,4-dimethyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-6-yl)-2-(piperidin-1-ylmethyl)biphenyl-4-carboxamide, having vanilloid receptor 1 antagonistic activity, used as analgesics
10/29/2009US20090269793 Compounds and Kits for the Detection and the Quantification of Cell Apoptosis
10/29/2009US20090267061 Carbonyl-Functionalized Thiophene Compounds and Related Device Structures
10/29/2009CA2722529A1 Substituted gamma lactams as therapeutic agents
10/29/2009CA2722454A1 Substituted gamma lactams as therapeutic agents
10/29/2009CA2722326A1 Macrocyclic compounds and their use as kinase inhibitors
10/29/2009CA2722031A1 Iminopyridine derivative and use thereof
10/28/2009EP2111395A1 New phenyl- (4-phenyl-pyrimidin-2-yl) - amines derivatives, preparation thereof as drugs, pharmaceutical compositions and use thereof essentially as ikk inhibitors
10/28/2009EP1272168B2 Small organic molecule regulators of cell proliferation
10/28/2009CN101568539A Imidazolidinonyl aminopyrimidine compounds for the treatment of cancer
10/28/2009CN101568538A Thiophene analogues for the treatment or prevention of flavivirus infections
10/28/2009CN101568537A Method for producing C-glycoside derivative and synthetic intermediate thereof
10/28/2009CN101567425A Organic electroluminescence device, novel platinum complex compound and novel compound capable of being a ligand thereof
10/28/2009CN101565416A Alkynyl thiophene ketone compound and preparation method and applications thereof
10/28/2009CN100554266C Aryl piperazine modified benzo [b] thiophene compound, and its preparing method and use
10/27/2009US7608718 4,5-dihydro-1H-pyrazole derivatives having potent CB1-antagonistic activity
10/27/2009US7608634 Substituted pyrrolines as kinase inhibitors
10/27/2009US7608632 Sulfonamide inhibitors of aspartyl protease
10/27/2009US7608629 Useful for the treatment of migraine and other 5-HT1F receptor associated disorders; for example, N-[3-(1-methyl-piperidin-4-yloxy)-phenyl]-2-furancarboxamide
10/27/2009US7608621 Such as n-{[2-[(4-bromo-2-fluorophenyl)methyl]-5-hydroxy-6-(1-methylethyl)-3-oxo-2,3-dihydro-4-pyridazinyl]carbonyl}glycine; anemia; increasing erythropoietin production
10/27/2009US7608618 1-(2,2,2-trifluoroethanoyl)pyrrolidine-2-carboxylic acid [4-methoxy-3-(3-pyrazin-2-yl-ureido)phenyl]-amide; 4-Methoxy-N-(3-methylamino-propyl)-3-(3-pyrazin-2-yl-ureido)-benzamide; checkpoint kinase Chk1 inhibitor; chemosensitizing agents useful in the treatment of diseases related to DNA damage
10/27/2009US7608590 19-(7-Methoxy-2-phenyl-quinolin-4-yloxy)-2, 16-dioxo-3,15,17-triaza-tricyclo[15.3.0.0*4,6*]icos-7-ene-4,14-dicarboxylic acid 4-ethyl ester 14-methyl ester, for example; inhibits the NS3 protease of flavivirus such as hepatitis C virus (HCV)
10/27/2009US7608563 3-phenoxy-4-pyridazinol derivatives and herbicide composition containing the same
10/27/2009CA2506441C 5-substituted-pyrazine or pyridine glucokinase activators
10/27/2009CA2466724C Benzamide and heteroarylamide as p2x7 receptor antagonists
10/27/2009CA2376355C N-heterocyclic derivatives as nos inhibitors
10/22/2009WO2009128537A1 Heterocyclic compound
10/22/2009WO2009128262A1 Quinolone derivative and use thereof
10/22/2009WO2009127722A1 Novel microbiocides
10/22/2009WO2009127686A1 Novel estrogen receptor ligands
10/22/2009WO2009127417A1 Quinoline derivatives as axl kinase inhibitors
10/22/2009WO2009102428A3 1,3-OXAZEPAN-2-ONE AND 1,3-DIAZEPAN-2-ONE INHIBITORS OF 11β -HYDROXYSTEROID DEHYDROGENASE 1
10/22/2009WO2008110355A8 Quinoline derivatives as fungicides
10/22/2009US20090264474 Sulfonamides as trpm8 modulators
10/22/2009US20090264469 Novel dicarboxylic acid derivatives
10/22/2009US20090264451 6-1h-imidazo-quinazoline and quinolines derivatives, new potent analgesics and anti-inflammatory agents
10/22/2009US20090264424 Vanilloid receptor ligands and their use in treatments
10/22/2009US20090264416 N-benzyl,n'-arylcarbonylpiperazine derivatives
10/22/2009US20090264404 Derivatives of 4-piperazin-1-yl-4-benzo[b]thiophene suitable for the treatment of cns disorders
10/22/2009DE102008019907A1 Pyridazinonderivate Pyridazinone derivatives
10/22/2009CA2721203A1 Inhibitors of protein phosphatase-1 and uses thereof
10/22/2009CA2720215A1 Novel estrogen receptor ligands
10/22/2009CA2718538A1 Quinoline derivatives as axl kinase inhibitors
10/21/2009EP1979320B1 PIPERAZINES AND PIPERIDINES AS mGluR5 POTENTIATORS
10/21/2009EP1515724B1 Mitotic kinesin inhibitors
10/21/2009EP1492785B9 2-hydroxy-3-heteroarylindole derivatives as gsk3 inhibitors
10/21/2009EP1448526B1 Piperidine-based mch antagonists for treatment of obesity and cns disorders
10/21/2009EP1426365B9 3-phenoxy-4-pyridazinol derivative and herbicide composition containing the same
10/21/2009EP1381366B9 Indole, azaindole and related heterocyclic amidopiperazine derivatives
10/21/2009EP1322624B1 Arylalkane-sulfonamides having endothelin-antagonist activity
10/21/2009CN101563342A Imidazolidinonyl aminopyrimidine compounds for the treatment' of cancer
10/21/2009CN101563322A 1H-indole-2-carboxylic acid derivatives useful as PPAR modulators
10/21/2009CN101563319A Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives
10/21/2009CN101560191A Alpha-menaphthyl substituted spiro bis(oxazoline) ligands, synthetic method and application thereof in synthesizing pyrazolidine derivatives
10/21/2009CN101560186A Novel organic electroluminescent compounds and organic electroluminescent device using the same
10/21/2009CN101559053A 5-membered heterocycle derivatives, production thereof and use thereof as medicaments
10/20/2009US7605277 N,N'-Di(1-naphthyl)-N,N'-diphenyl-2,6-diaminodibenzodioxin; organic electroelement hole-transporting layer, light-emitting material, a host materialor dopant in the light-emitting layer,a hole-blocking layer, an electron-transporting layer;high luminous efficiency; high heat resistance; durability
10/20/2009US7605164 Compositions and methods for treating heart failure
10/20/2009US7605159 Cathepsin cysteine protease inhibitors and their use
10/20/2009US7605111 Herbicides
10/20/2009US7604874 having an anthracene compound substituted with at least one thiophenyl ring; OLED organic light emitters; as displays with low power consumption, faster response time, higher brightness level, unlimited viewing angle
10/20/2009CA2385130C Novel spiroheterocyclic compounds useful as reversible inhibitors of cysteine proteases
10/20/2009CA2368993C C7 ester substituted taxanes as antitumor agents
10/20/2009CA2314685C A novel crystalline form of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy] phenoxy)-2-(4-methoxyphenyl) benzo[b]thiophene hydrochloride
10/20/2009CA2214793C Novel intermediates and process for the manufacture of camptothecin derivatives (cpt-11) and related compounds
10/15/2009WO2009125870A1 Pyrimidine, pyridine and triazine derivatives as maxi-k channel openers.
10/15/2009WO2009125853A1 Homocysteine synthase inhibitor
10/15/2009WO2009125597A1 Acylthiourea compound or salt thereof, and use of the compound or the salt
10/15/2009WO2009125434A2 Oxime derivatives
10/15/2009WO2009124968A1 Novel estrogen receptor ligands
10/15/2009WO2009085344A3 Dibenzothiophene, dibenzofuran and/or carbazole-containing materials in phosphorescent light emitting diodes
10/15/2009WO2009013760A3 Eprosartan mesylate crystalline particles and a process for preparing pure eprosartan
10/15/2009WO2008086226A8 Factor xa inhibitors
10/15/2009US20090258922 Compound exhibiting pgd2 receptor antagonist
10/15/2009US20090258909 Novel Benzimidazole Derivatives Useful as Selective Androgen Receptor Modulators (SARMS)
10/15/2009US20090258906 Cxcr2 antagonists
10/15/2009US20090258899 Derivatives of pyrrolizine, indolizine and quinolizine, preparation thereof and therapeutic use thereof
10/15/2009US20090258884 Substituted amides
10/15/2009CA2725425A1 Homocysteine synthase inhibitor
10/15/2009CA2720552A1 Acylthiourea compound or salt thereof, and use thereof
10/14/2009EP2108649A1 Novel indol carboxylic acid bispyridyl carboxamide derivatives as 5-HT2c receptor antagonists
10/14/2009EP2108012A2 Substituted n-(4-cyano-1h-pyrazol-3-yl)methylamine derivatives, preparation thereof and therapeutic use thereof
1 ... 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 ... 523